CJEU adviser to give opinion on SPC term

An adviser at Europe’s highest court is expected to issue an opinion on whether the term of a supplementary protection certificate (SPC) begins once it is authorised or when the applicant has been notified about it.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Video interview: Hogan Lovells discusses implications of Brexit on SPCs

25 August 2016 In an exclusive interview with LSIPR, Stephen Bennett, partner at Hogan Lovells, talks about the implications of Brexit with a focus on supplementary protection certificates.

Biotechnology

SPCs should start once authorisation is broadcast, says AG

10 September 2015 Supplementary protection certificates should take effect once an applicant for marketing authorisation has been notified of the authorisation, an advocate-general has urged the Court of Justice of the European Union to confirm.

More features

The Quintara decision: Defining trade secrets in federal cases

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

CJEU adviser to give opinion on SPC term

More on this story

Editor's picks

Editor's picks

More features